Early observations on duchenne-meryon muscular dystrophy.
نویسنده
چکیده
cles, loss of ambulation by adolescence, and early death. His harpoon muscle biopsies established the loss of muscle fi bre striation, hyperplasia of fi brous connective tissue with replacement by granular matter and fat vesicles, and fascicular atrophy of the muscles and destruction of the muscle as essential features. Duchenne wrote [4] : ‘This disease is mainly characterised: (1) By feebleness of movement, usually situated at fi rst in the muscles Duchenne muscular dystrophy is an X-linked recessive, progressive muscle-wasting disease affecting all world populations equally, with an incidence of about 1 in every 5,000 live male births. Duchenne made use of his invention, the ‘harpoon’ that he employed to perform percutaneous muscle biopsies; not surprisingly, this aroused hostile criticism of its ethical propriety, in the local press. The discovery of pseudohypertrophic paralysis, or myosclerotic paralysis in 1868 [1] , was however, a remarkable and important contribution [2] , dependent on and illustrated by pictures of histology obtained by harpoon biopsy. In 1858, he studied the case of a 9-year-old boy who could not walk because of muscle wasting. He had suspected the existence of this disease from the concurrence of the characteristic symptoms, and in the second edition of De l’Electrisation localisée [3] he published his fi rst description, and proposed the name ‘hypertrophic paraplegia of infancy’. His fi rst case crystallised the essential features: ‘Paralysie pseudo-hypertrophique; début dans la première enfance, par la faiblesse des membres inférieurs; grossissement considérable, à l’âge de 7 ans, des muscles moteurs des membres inférieurs et des extenseurs de la colonne vertébro-lombaire; généralisation progressive de la paralysie et abolition complète de tous les mouvements, à 13 ans et demi; intelligence obtuse; mort phthisique, à 15 ans’. He described the male predominance, progressive course, waddling gait, pseudo-hypertrophy of calf musReceived: April 18, 2005 Accepted: April 18, 2005 Published online: August 10, 2005
منابع مشابه
The dystrophy of Duchenne.
Duchenne muscular dystrophy While the eponym, Duchenne muscular dystrophy (DMD), is applied to the most common and most severe muscular dystrophy of childhood, Duchenne was not the first to describe the condition. 10 years before Duchenne reported his first case of Duchenne dystrophy, the London physician Meryon had described the condition. However, Duchenne provided a comprehensive account of ...
متن کاملP164: Adeno-Associated Viral Vectors in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (BMD) is an inherited X-link disease. The incidence of this muscle-wasting disease is 1:5000 male live births. Mutation in the gene coding for dystrophin is the main cause of BMD. Most cases of this disease succumb to respiratory and cardiac failure in 3rd to 4th decades. The slow progression of BMD and recent achievement of gene therapies make it as an appropriate c...
متن کاملDetection of the Duplication in Exons 56-63 of Duchenne Muscular Dystrophy Patients with MLPA
Background Duchenne Muscular Dystrophy (DMD) is a deadly X-linked recessive disorder. This genetic disorder affects 1 among 3,500-5,000 males in the world. The majority of the patients are male, due to the type of inheritance. It affects most of the skeletal, the respiratory, and cardiac muscles, causing these vital organs to contract and eventually mortality.<br...
متن کاملMuscle - Specific Autoantibody to Carbonic Anhydrase Iii in a Patient with Myofibrillar Myopathy
5th Aim Congress ITALIAN ASSOCIATION FOR MYOLOGY Jolly Hotel delle Terme – Ischia, Naples, Italy, June 16-18, 2005 Foreward I am delighted to be asked to write a foreward to the 5 Meeting of Italian Society of Myology, since this is a remarkably comprehensive meeting and contributes significantly to our store of knowledge in Myology with several oral communications, posters and case presentatio...
متن کاملDuchenne Muscular Dystrophy Mice and Men
Duchenne muscular dystrophy mouse models have a predictable and reproducible time course of cardiomyopathy progression with discrete pathogenic steps, which closely parallel what we know occurs in the cardiomyopathy of patients with Duchenne muscular dystrophy. The slow progression of early pathogenic steps common to many cardiomyopathies may make Duchenne muscular dystrophy models useful for i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- European neurology
دوره 54 1 شماره
صفحات -
تاریخ انتشار 2005